Show Notes
In this episode of The Good GP, Dr Sean Stevens speaks with Dr Terri-Lynne South, GP and medical director of Lifestyle Metabolic, for a focused discussion on the practicalities of prescribing GLP-1 medications. Dr Terri-Lynne shares her experience with increasing GP interest in GLP-1s, outlining both established and new indications such as type 2 diabetes, obesity, cardiovascular disease prevention, metabolic-associated steatotic liver disease (MASLD), chronic kidney disease, and obstructive sleep apnea.
Dr Terri-Lynne provides clear, evidence-based guidance on dose titration, emphasising the importance of starting low and progressing gradually to minimise side effects, with schedules tailored to individual patient response. She recommended baseline and follow-up monitoring, including the use of the Bristol stool chart for baseline gastrointestinal assessment.
Examining physiological effects and timelines following the discontinuation of GLP-1 therapy, with typical patterns of weight regain and metabolic reversal.
Finally, highlighting the evolving role of GLP-1s as disease-modifying agents and flags upcoming advances such as dual and triple agonists and new oral medications. Dr Terri-Lynne concludes by advising GPs to set realistic patient expectations and understand the long-term management necessities of chronic disease.
The Good GP Podcast is a proud member of the Talking HealthTech Podcast Network - the premier audio destination for cutting-edge insights and thought leadership in healthcare delivery, innovation, digital health, healthcare ICT, and commercialisation. Learn more at www.talkinghealthtech.com/podcast/network
If you have any questions or would like to contact The Good GP, send an email to [email protected]. Visit www.thegoodgp.com.au for previous episodes and more information. You can also find us on our Instagram page: @thegoodgppodcast. Follow us for more updates! Mentioned in this episode: Build the Career and Lifestyle You’ve Been Looking For, in the Vines. Tired of traffic, long commutes, and feeling stuck in the grind? The Mudgee Region is calling.
The Doctors 4 Mudgee Region initiative is working to attract and support GPs and registrars looking to build rewarding, sustainable careers in one of NSW’s most sought after regional destinations, just 3 hours from Sydney. With financial incentives of up to $45,000 for fellowed doctors and lifestyle concierge support for all relocating practitioners, there’s never been a better time to make the move.
Learn more at www.doctors4mudgee.com.au Doctors 4 Mudgee Region
More from The Good GP
In this episode of The Good GP, Dr Krystyna de Lange speaks with Dr Steph Daly, GP with a special interest in aged care and dementia, about the introduction of plasma biomarkers, specifically the p-Tau 217 blood test for Alzheimer’s disease. They explore what the p-Tau 217 test measures, its reliability, and its role in primary care.
In this episode of The Good GP, host Dr Krystyna De Lange speaks with Dr David Leitinger, a GP with a special interest in addiction medicine, about the practical use of naltrexone for managing alcohol use disorder (AUD).
In this episode of The Good GP, Dr Julia Rawlinson speaks with Dr Florence Martin, an epidemiologist specialising in pregnancy pharmacoepidemiology. Dr Martin discusses her recent study examining the relationship between first trimester antidepressant use and miscarriage risk, using UK primary care data from the CPRD GOLD database.
In this episode of the Good GP, Dr Julia Rawlinson speaks with Dr Julia Feutrill, consultant psychiatrist at King Edward Memorial Hospital and co-director of the Elizabeth Clinic. They discuss the complexities of antidepressant use during pregnancy, providing GPs with practical advice for navigating these conversations.
In this episode of the Good GP, Dr Julia Rawlinson speaks with Dr Paul Effler, Senior Medical Advisor at the WA Department of Health and expert in communicable diseases, about H5N1 avian influenza and pertussis.